Clinical therapeutics stands as a vital pillar in the realm of medical practice, intricately weaving pharmacological principles into the fabric of patient care. This dynamic field entrusts healthcare professionals with the task of applying their nuanced understanding of pharmacology to fine-tune therapeutic outcomes and safeguard the well-being of patients. At its core, pharmacology serves as a compass, guiding the selection of apt drugs by unraveling their mechanisms of action, pharmacokinetics, and pharmacodynamics. The art of clinical therapeutics unfolds through evidence-based decision-making, allowing clinicians to craft drug regimens that strike a delicate balance between maximal efficacy and minimal side effects. The adherence to dosage guidelines, a grasp of drug metabolism intricacies, and a keen awareness of potential adverse effects emerge as crucial linchpins in the pursuit of patient safety. The landscape of clinical therapeutics is not static but thrives on constant updates fueled by emerging drugs and research findings. This perpetual evolution underscores the discipline's commitment to evidence-based practices, ensuring that healthcare providers are armed with the latest insights to enhance patient care. In this ever-evolving terrain, pharmacogenomics emerges as a burgeoning frontier within clinical therapeutics. Delving into the genetic underpinnings of individual responses to drugs, it illuminates the path toward personalized medicine, heralding a new era of tailored treatment approaches.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia